Intraperitoneal stability of alginate-polyornithine microcapsules in rats: An FTIR and SEM analysis

Biomaterials

Volumn 27, Issue 19, 2006, Pages 3570-3579

  Thanos, Christopher G ^a,b   Bintz, Briannan E ^a   Bell, William J ^a   Qian, Haitao ^b   Schneider, Patricia A ^a   MacArthur, Daniel H ^b   Emerich, Dwaine F ^a  

^a LCT BioPharma Inc   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

Alginate; Biodegradation; Cell encapsulation; FTIR; Hydrogel; SEM

Indexed keywords

BIODEGRADATION; CELLS; CROSSLINKING; FOURIER TRANSFORM INFRARED SPECTROSCOPY; HYDROGELS; POLYSACCHARIDES; PROTEINS; SCANNING ELECTRON MICROSCOPY;

ALGINATE; CELL ENCAPSULATION; INTRAPERITONEAL STABILITY; POLYORNITHINE;

ORGANIC COMPOUNDS;

ALGINIC ACID; POLYORNITHINE; PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ENCAPSULATION; CELL TRANSPLANTATION; CONTROLLED STUDY; CROSS LINKING; HYDROGEL; INFRARED SPECTROSCOPY; MALE; MICROCAPSULE; MORPHOMETRICS; NONHUMAN; PERITONEAL CAVITY; PRIORITY JOURNAL; PROTEIN CONTENT; PURIFICATION; RAT; RAT STRAIN; SCANNING ELECTRON MICROSCOPY; TITRIMETRY;

ALGINATES; ANIMALS; BIOCOMPATIBLE MATERIALS; CAPSULES; DRUG DELIVERY SYSTEMS; DRUG STABILITY; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MATERIALS TESTING; MICROSCOPY, ELECTRON, SCANNING; MOLECULAR STRUCTURE; PEPTIDES; PERITONEAL CAVITY; RATS; RATS, LONG-EVANS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SURFACE PROPERTIES;

ANIMALIA;

EID: 33645859044     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2006.01.042     Document Type: Article

References (36)

1. Murphy G.P., Mundy R.L., and Ewald R.A. The physiologic properties of glyco-alginate, a new Japanese plasma-volume expander. Surgery 56 (1964) 1099-1108
2. Kierstan M., and Bucke C. The immobilization of microbial cells, subcellular organelles, and enzymes in calcium alginate gels. Biotechnol Bioeng 19 3 (1977) 387-397
3. Fan M.Y., Lum Z.P., Fu X.W., Levesque L., Tai I.T., and Sun A.M. Reversal of diabetes in BB rats by transplantation of encapsulated pancreatic islets. Diabetes 39 4 (1990) 519-522
4. Fritschy W.M., Wolters G.H., and van Schilfgaarde R. Effect of alginate-polylysine-alginate microencapsulation on in vitro insulin release from rat pancreatic islets. Diabetes 40 1 (1991) 37-43
5. Hobbs H.A., Kendall Jr. W.F., Darrabie M., and Opara E.C. Prevention of morphological changes in alginate microcapsules for islet xenotransplantation. J Invest Med 49 6 (2001) 572-575
6. Korbutt G.S., Mallett A.G., Ao Z., Flashner M., and Rajotte R.V. Improved survival of microencapsulated islets during in vitro culture and enhanced metabolic function following transplantation. Diabetologia 47 10 (2004) 1810-1818
7. Leung Y.F., O'Shea G.M., Goosen M.F., and Sun A.M. Microencapsulation of crystalline insulin or islets of Langerhans: an insulin diffusion study. Artif Organs 7 2 (1983) 208-212
8. Schrezenmeir J., Kirchgessner J., Gero L., Kunz L.A., Beyer J., and Mueller-Klieser W. Effect of microencapsulation on oxygen distribution in islets organs. Transplantation 57 9 (1994) 1308-1314
9. Trivedi N., Keegan M., Steil G.M., Hollister-Lock J., Hasenkamp W.M., Colton C.K., et al. Islets in alginate macrobeads reverse diabetes despite minimal acute insulin secretory responses. Transplantation 71 2 (2001) 203-211
10. Wang T., Lacik I., Brissova M., Anilkumar A.V., Prokop A., Hunkeler D., et al. An encapsulation system for the immunoisolation of pancreatic islets. Nat Biotechnol 15 4 (1997) 358-362
11. Joseph J.M., Goddard M.B., Mills J., Padrun V., Zurn A., Zielinski B., et al. Transplantation of encapsulated bovine chromaffin cells in the sheep subarachnoid space: a preclinical study for the treatment of cancer pain. Cell Transplant 3 5 (1994) 355-364
12. Garcia-Martin C., Chuah M.K., Van Damme A., Robinson K.E., Vanzieleghem B., Saint-Remy J.M., et al. Therapeutic levels of human factor VIII in mice implanted with encapsulated cells: potential for gene therapy of haemophilia A. J Gene Med 4 2 (2002) 215-223
13. Hortelano G., Al-Hendy A., Ofosu F.A., and Chang P.L. Delivery of human factor IX in mice by encapsulated recombinant myoblasts: a novel approach towards allogeneic gene therapy of hemophilia B. Blood 87 12 (1996) 5095-5103
14. Aebischer P., Tresco P.A., Sagen J., and Winn S.R. Transplantation of microencapsulated bovine chromaffin cells reduces lesion-induced rotational asymmetry in rats. Brain Res 560 1-2 (1991) 43-49
15. Borlongan C.V., Skinner S.J., Geaney M., Vasconcellos A.V., Elliott R.B., and Emerich D.F. Neuroprotection by encapsulated choroid plexus in a rodent model of Huntington's disease. Neuroreport 15 16 (2004) 2521-2525
16. Borlongan C.V., Skinner S.J., Geaney M., Vasconcellos A.V., Elliott R.B., and Emerich D.F. Intracerebral transplantation of porcine choroid plexus provides structural and functional neuroprotection in a rodent model of stroke. Stroke 35 9 (2004) 2206-2210
17. Borlongan C.V., Skinner S.J., Geaney M., Vasconcellos A.V., Elliott R.B., and Emerich D.F. CNS grafts of rat choroid plexus protect against cerebral ischemia in adult rats. Neuroreport 15 10 (2004) 1543-1547
18. Maysinger D., Piccardo P., Filipovic-Grcic J., and Cuello A.C. Microencapsulation of genetically engineered fibroblasts secreting nerve growth factor. Neurochem Int 23 2 (1993) 123-129
19. Maysinger D., Piccardo P., Liberini P., Jalsenjak I., and Cuello C. Encapsulated genetically engineered fibroblasts: release of nerve growth factor and effects in vivo on recovery of cholinergic markers after devascularizing cortical lesions. Neurochem Int 24 5 (1994) 495-503
20. Ross C.J., and Chang P.L. Development of small alginate microcapsules for recombinant gene product delivery to the rodent brain. J Biomater Sci Polym Ed 13 8 (2002) 953-962
21. Tresco P.A., Winn S.R., and Aebischer P. Polymer encapsulated neurotransmitter secreting cells. Potential treatment for Parkinson's disease. Asaio J 38 1 (1992) 17-23
22. Visted T., Bjerkvig R., and Enger P.O. Cell encapsulation technology as a therapeutic strategy for CNS malignancies. Neuro-oncology 3 3 (2001) 201-210
23. Winn S.R., Tresco P.A., Zielinski B., Greene L.A., Jaeger C.B., and Aebischer P. Behavioral recovery following intrastriatal implantation of microencapsulated PC12 cells. Exp Neurol 113 3 (1991) 322-329
24. Xue Y., Gao J., Xi Z., Wang Z., Li X., Cui X., et al. Microencapsulated bovine chromaffin cell xenografts into hemiparkinsonian rats: a drug-induced rotational behavior and histological changes analysis. Artif Organs 25 2 (2001) 131-135
25. Boontheekul T., Kong H.J., and Mooney D.J. Controlling alginate gel degradation utilizing partial oxidation and bimodal molecular weight distribution. Biomaterials 26 15 (2005) 2455-2465
26. Bouhadir K.H., Lee K.Y., Alsberg E., Damm K.L., Anderson K.W., and Mooney D.J. Degradation of partially oxidized alginate and its potential application for tissue engineering. Biotechnol Prog 17 5 (2001) 945-950
27. Kendall W., Darrabie M., Freeman B., Hobbs H., Collins B., and Opara E. Effect of bead swelling on the durability of polylysine alginate microcapsules. Curr Surg 57 6 (2000) 636-637
28. Kendall Jr. W.F., Darrabie M.D., El-Shewy H.M., and Opara E.C. Effect of alginate composition and purity on alginate microspheres. J Microencapsul 21 8 (2004) 821-828
29. Kong H.J., Kaigler D., Kim K., and Mooney D.J. Controlling rigidity and degradation of alginate hydrogels via molecular weight distribution. Biomacromolecules 5 5 (2004) 1720-1727
30. Lee K.Y., Bouhadir K.H., and Mooney D.J. Controlled degradation of hydrogels using multi-functional cross-linking molecules. Biomaterials 25 13 (2004) 2461-2466
31. De Vos P., De Haan B., and Van Schilfgaarde R. Effect of the alginate composition on the biocompatibility of alginate-polylysine microcapsules. Biomaterials 18 3 (1997) 273-278
32. De Vos P., De Haan B.J., Wolters G.H., Strubbe J.H., and Van Schilfgaarde R. Improved biocompatibility but limited graft survival after purification of alginate for microencapsulation of pancreatic islets. Diabetologia 40 3 (1997) 262-270
33. Bunger C.M., Gerlach C., Freier T., Schmitz K.P., Pilz M., Werner C., et al. Biocompatibility and surface structure of chemically modified immunoisolating alginate-PLL capsules. J Biomed Mater Res A 67 4 (2003) 1219-1227
34. Grasdalen H., Larsen B., and Smidsrod O. A P.M.R. study of the composition and sequence of uronate residues in alginates. Carbohyd Res 68 (1979) 23-31
35. van Hoogmoed C.G., Busscher H.J., and de Vos P. Fourier transform infrared spectroscopy studies of alginate-PLL capsules with varying compositions. J Biomed Mater Res A 67 1 (2003) 172-178
36. Nakagawa Y., Murai T., Hasegawa C., Hirata M., Tsuchiya T., Yagami T., et al. Endotoxin contamination in would dressings made of natural biomaterials. J Biomed Mater Res 66B (2003) 347-355